Form CORRESP - Correspondence:
SEC Accession No. 0001493152-24-052439
Filing Date
2024-12-30
Accepted
2024-12-30 13:44:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10142
  Complete submission text file 0001493152-24-052439.txt   11371
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)